Evaluation of new anti-infective drugs for the treatment and prevention of tuberculosis. Infectious Diseases Society of America and the Food and Drug Administration.
Hopewell, P
Evaluation of new anti-infective drugs for the treatment and prevention of tuberculosis. Infectious Diseases Society of America and the Food and Drug Administration. [electronic resource] - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Nov 1992 - S282-95 p. digital
Publication Type: Guideline; Journal Article; Practice Guideline; Research Support, U.S. Gov't, P.H.S.
1058-4838
10.1093/clind/15.supplement_1.s282 doi
Adult
Antitubercular Agents--therapeutic use
Child
Clinical Protocols--standards
Clinical Trials as Topic--standards
Clinical Trials, Phase I as Topic--standards
Clinical Trials, Phase II as Topic--standards
Clinical Trials, Phase III as Topic--standards
Humans
Research Design
Tuberculosis--drug therapy
Evaluation of new anti-infective drugs for the treatment and prevention of tuberculosis. Infectious Diseases Society of America and the Food and Drug Administration. [electronic resource] - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Nov 1992 - S282-95 p. digital
Publication Type: Guideline; Journal Article; Practice Guideline; Research Support, U.S. Gov't, P.H.S.
1058-4838
10.1093/clind/15.supplement_1.s282 doi
Adult
Antitubercular Agents--therapeutic use
Child
Clinical Protocols--standards
Clinical Trials as Topic--standards
Clinical Trials, Phase I as Topic--standards
Clinical Trials, Phase II as Topic--standards
Clinical Trials, Phase III as Topic--standards
Humans
Research Design
Tuberculosis--drug therapy